Professional Medical Expertise Co.

9574.SRSAUHealthcare● Active

$85.70

+$0.10(+0.12%)

Market Cap$299950000

P/E Ratio—

52W High$107

52W Low$75

Avg Volume2K

Open$85.70

Beta-0.17

Free Cash Flow Financials Revenue

Professional Medical Expertise Co. (9574.SR) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

9574.SR · free cash flow · updated Jun 15, 2026

Core FCF metrics

9574.SR · FCF · TTM · margin & CAGR

Free cash flow was −$34.4M for FY2025 (fiscal year ending 2025-12-31), down 83.0% year-over-year The FCF margin was -8.2%.

FY2025 Free Cash Flow−$34.4M▼ -83.0% YoY

Trailing 12M (TTM)−$1.3Mtrailing 4 quarters sum

FCF Margin-8.2%−$34.4M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 15, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

9574.SR · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$10.2M(24M)−$34.4M▼ 83.0%-8.2%

FY2024−$1.9M(7M)−$18.8M▼ 507.3%-6.0%

FY2023$5.9M(9M)−$3.1M▲ +79.0%-1.2%

FY2022−$8.3M(7M)−$14.8M▼ 197.4%-8.4%

FY2021$18.5M(3M)$15.2M▲ +75.3%11.6%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

9574.SR · P/FCF · FCF yield · FCF per share

Professional Medical Expertise Co. (9574.SR) reported negative free cash flow of −$0.03B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

9574.SR · cash flow statement · operating / investing / financing

For FY2025, Professional Medical Expertise Co. generated −$10.2M in operating cash flow and spent 24M in capital expenditures, yielding −$34.4M in free cash flow.

Operating Activities

−$10.2M

Cash from core business operations

2025-12-31

Investing Activities

−$15.8M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$25.0M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF (−$10.2M) − |CapEx| (24M) = FCF (−$34.4M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

9574.SR vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Professional Medical Expertise Co.YOU

9574.SR

−$34.4M-83.0%-8.2%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Professional Medical Expertise Co. (9574.SR) reported free cash flow of −$34.4M for FY2025 (fiscal year ending 2025-12-31), down 83.0% year-over-year. The FCF margin was -8.2%.

Based on available data, Professional Medical Expertise Co. has maintained positive free cash flow for at least 2 fiscal year(s). FCF peaked at $15.2M in FY2021.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

9574.SR free cash flow · 8 questions

Professional Medical Expertise Co. free cash flow was −$34.4M for FY2025, down 83.0% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$1.3M.

9574.SR free cash flow9574.SR FCF9574.SR FCF 20259574.SR free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Professional Medical Expertise Co. · Professional Medical Expertise Co. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026